Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®

(2011) Didier B. Hans et al.   JOURNAL OF CLINICAL DENSITOMETRY

Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture

(2011) Edward S. Leib et al.   JOURNAL OF CLINICAL DENSITOMETRY

Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality

(2011) N. Emaus et al.   OSTEOPOROSIS INTERNATIONAL

Guidance for the adjustment of FRAX according to the dose of glucocorticoids

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Interpretation and use of FRAX in clinical practice

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Secular trends in the incidence of hip and other osteoporotic fractures

(2011) C. Cooper et al.   OSTEOPOROSIS INTERNATIONAL

Development of a simple prognostic nomogram for individualising 5-year and 10-year absolute risks of fracture: a population-based prospective study among postmenopausal women

(2010) T. A. C. M. van Geel et al.   ANNALS OF THE RHEUMATIC DISEASES

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

(2010) Bertha Maria Verdel et al.   BONE

Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration

(2010) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Use of Organic Nitrates and the Risk of Hip Fracture: A Population-Based Case-Control Study

(2010) Sander Pouwels et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos

(2010) L.-A. Fraser et al.   OSTEOPOROSIS INTERNATIONAL

A FRAX® model for the assessment of fracture probability in Belgium

(2010) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study

(2010) M. E. L. Arbouw et al.   OSTEOPOROSIS INTERNATIONAL

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

(2010) S. Pouwels et al.   OSTEOPOROSIS INTERNATIONAL

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

(2009) J. Compston et al.   MATURITAS

Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study

(2009) S. Pouwels et al.   OSTEOPOROSIS INTERNATIONAL

Use of anti-depressants and the risk of fracture of the hip or femur

(2009) M. W. M. van den Brand et al.   OSTEOPOROSIS INTERNATIONAL

Risk of Hip/Femur Fracture After Stroke

(2009) Sander Pouwels et al.   STROKE

From relative risk to absolute fracture risk calculation: The FRAX algorithm

(2009) Eugene V. McCloskey et al.   Current Osteoporosis Reports

A Simple Risk Score for the Assessment of Absolute Fracture Risk in General Practice Based on Two Longitudinal Studies

(2008) Saskia MF Pluijm et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL